Sign up & Download
Sign in

Neurologic uses of botulinum neurotoxin type A

by John P. Ney, Kevin R. Joseph
Neuropsychiatric Disease and Treatment ()


This article reviews the current and most neurologic uses of botulinum neurotoxin type A (BoNT-A), beginning with relevant historical data, neurochemical mechanism at the neuromuscular junction. Current commercial preparations of BoNT-A are reviewed, as are immunologic issues relating to secondary failure of BoNT-A therapy. Clinical uses are summarized with an emphasis on controlled clinical trials (as appropriate), including facial movement disorders, focal neck and limb dystonias, spasticity, hypersecretory syndromes, and pain.

Cite this document (BETA)

Available from
Page 1
Page 2

Readership Statistics

20 Readers on Mendeley
by Discipline
by Academic Status
35% Student (Master)
20% Student (Bachelor)
10% Ph.D. Student
by Country
5% Brazil
5% United States

Sign up today - FREE

Mendeley saves you time finding and organizing research. Learn more

  • All your research in one place
  • Add and import papers easily
  • Access it anywhere, anytime

Start using Mendeley in seconds!

Sign up & Download

Already have an account? Sign in